Rx Communications...

making accurate, valuable information accessible

A Boutique Medical Communications Agency

Why choose Rx Communications?

  • The longest established and largest medical communications agency specialising in health economics and outcomes communications, publications and training
  • One of the most ethical and compliant medical communications agencies in healthcare today
  • A leader in innovative communications and publications, strategic planning and management
Why choose Rx

Customer Testimonials

Sadly, the confidential nature of our work means that our client testimonials are anonymous, but we still think it’s important for you know what they think of us anyway!

I wanted to tell you what an excellent job you and your group have done in making this task easy for me.

Author

The research was very thorough and the concepts were integrated in a very sophisticated manner. Also the writing style was very smooth and comprehensible and very easy for me to work from.

Author

Thank you so much for having your internal reviewers edit these posters. I must say that I was very impressed with their findings, edits, and scientific acumen!

Author & KOL

Your efforts were and are highly appreciated and demonstrated the ability of your organisation to work very well under pressure.

Health Economist

Great job, with the writing, the timelines and reminders to the authors. It’s a real pleasure to work with you and your team.

Senior Medical Advisor

We are almost done…Thanks to you and your team for excellent work on this manuscript.

Author

Latest news from the Health Economics & Outcomes World

  • FDA’s OCE, Sypase Partner on RWE

    The Food and Drug Administration’s Oncology Center of Excellence (OCE) and Syapse are joining forces to bolster the use of real-world evidence to leap over hurdles in trials, Endpoints News […]

  • Tufts Health Plan, Harvard Pilgrim to Merge

    Tufts Health Plan and Harvard Pilgrim Health Care this week announced to merge, HealthPayerIntelligence reports. “Building upon our collective synergies and strengths — which includes […]

  • ICER Releases Final Report on DMD Treatments

    The Institute for Clinical and Economic Review (ICER) on Thursday, Aug. 15, released its final report on treatments for Duchenne muscular dystrophy (DMD). ICER reviewed three drugs for DMD: PTC […]

Health Outcomes Communicator (HOC)

Read more

HOC Sign-Up

Get our Health Outcomes Communicator direct to your inbox – sign-up now!

Please note: we will not pass your details on to any third-parties.  View our Privacy Policy here.